T. Rowe Price Associates
TRIL

T. Rowe Price Associates’s Trillium Therapeutics Inc. TRIL Stock Holding History

T. Rowe Price Associates’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-512,407
Closed -$4.15M – 2640
2020
Q2 		$4.15M Buy
+512,407
New +$4.15M ﹤0.01% 1402